Riskpilot← Back to searchSign inGet full accessVimian Medtech Holding AB
ABActiveOrg 5591921217Economic activity was not specified by tax authority · NACE 0000Est. 20190 employees
Revenue 2024
SEK 0
EBITDA margin
—
-5400% vs 2023
Equity ratio
47.2%
Financial strength
Net profit 2024
SEK -18,2M
-52% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -715K | -5400% |
| Net profit | SEK -18,2M | -52% |
| Total assets | SEK 3B | +49% |
| Equity | SEK 1,4B | -1% |
| Employees | 0 | — |
Legal name
Vimian Medtech Holding AB
Org number
5591921217
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
22 januari 2019
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget har till föremål för sin verksamhet att, direkt eller indirekt, äga och förvalta aktier och andelar i dotterbolag och intressebolag verksamma inom bland annat djurhälsovård och idka därmed förenlig verksamhet samt för sin verksamhet äga och förvalta fast och lös egendom samt illhandhålla övriga bolag i koncernen med tjänster främst avseende administration, styrning, juridisk rådgivning och marknadsföring samt idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — |
| EBITDA | — | −36 | −110 | −7 | −13 | −715 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −36 | −110 | −7 | −13 | −715 |
| Net financials | — | −754 | −4 328 | 214 | 3 008 | −60 012 |
| Profit before tax | −26 | −790 | −4 438 | −14 923 | −11 964 | −16 412 |
| Tax | −0 | −0 | −0 | −0 | −0 | −1 797 |
| Net profit | −26 | −790 | −4 438 | −14 923 | −11 964 | −18 209 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 77 930 | 787 852 | 1 407 144 | 1 750 320 | 2 010 325 | 2 987 503 |
| Equity | 65 378 | 660 284 | 1 332 015 | 1 441 451 | 1 429 487 | 1 411 278 |
| Long-term debt | 12 500 | 127 517 | 75 077 | 308 843 | 563 372 | 1 574 380 |
| Short-term debt | 52 | 52 | 51 | 26 | 17 466 | 1 846 |
| Total debt | 12 552 | 127 569 | 75 128 | 308 869 | 580 838 | 1 576 226 |
EBITDA margin
-71500000.0%
This company
15.8%
Market median
-452531746% vs market
20192024
Equity ratio
47.2%
This company
38.2%
Market median
+24% vs market
20192024
Return on equity
-1.3%
This company
18.4%
Market median
-107% vs market
20192024
Net profit margin
-1820900000.0%
This company
8.1%
Market median
-22480247014% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
1.12×
This company
0.62×
Market median
-81% vs market
20192024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EC Chief Auditor | Chief Auditor | 2026 | — | — |
CR Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Vimian FinCo AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Fidelio Vet Holding ABVimian Group ABVimian FinCo AB
Vimian Medtech Holding AB (this company)Ossium Holdco LlcOSSIUM HOLDCO LLCBoard members of Vimian Medtech Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Camilla Nilsson | Chief Auditor | 0 companies |
| Carl-Johan Regell | Chief Auditor | 0 companies |
| Carl Johan Vilhelm Ehn | Board of Directors | 0 companies |
| Carl Gabriel Lindsay Fitzgerald | Chairman | 0 companies |
| Carl Fredrik Michael Ullman | Chairman | 0 companies |
| Theodor Simon Josef Bonnier | Board of Directors | 0 companies |
| Martin A M Grabe Bengtson | Board of Directors | 0 companies |
| Carl-Johan T Zetterberg Boudrie | Chairman | 0 companies |
| Guy Cyril Spörri | Board of Directors | 0 companies |
| Jacob Olof Wiström | Board of Directors | 0 companies |